- Home
- HCM vs MNR Comparison
HCM vs MNR Comparison
Compare HCM & MNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HCM | MNR |
|---|---|---|
| Founded | 2000 | 2017 |
| Country | Hong Kong | United States |
| Employees | 1796 | 840 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | HCM | MNR |
|---|---|---|
| Price | $12.01 | $14.05 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $13.75 | ★ $18.00 |
| AVG Volume (30 Days) | 27.8K | ★ 554.8K |
| Earning Date | 03-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 14.29% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,175,390,000.00 |
| Revenue This Year | $20.60 | $34.60 |
| Revenue Next Year | $15.62 | $2.35 |
| P/E Ratio | $5.49 | ★ N/A |
| Revenue Growth | N/A | ★ 21.22 |
| 52 Week Low | $11.72 | $10.46 |
| 52 Week High | $19.50 | $15.58 |
Technical Indicators
Market Signals| Indicator | HCM | MNR |
|---|---|---|
| Relative Strength Index (RSI) | 26.82 | 53.42 |
| Support Level | N/A | $13.86 |
| Resistance Level | $15.75 | $14.35 |
| Average True Range (ATR) | 0.32 | 0.38 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 16.67 | 53.56 |
Price Performance
Historical ComparisonAbout HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
About MNR Mach Natural Resources LP
Mach Natural Resources LP is an independent upstream oil and gas company. The company is focused on the acquisition, development and production of oil, natural gas, and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas and the panhandle of Texas; the San Juan Basin region of New Mexico and Colorado; and the Permian Basin region of West Texas. The company is organized and managed as a single reportable segment, which is the exploration and production of oil, natural gas and NGLs (E&P Segment).